Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06288399
Status:
COMPLETED
Last Update Posted:
2024-04-09
First Post:
2024-02-23
Brief Title:
Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region A Retrospective Observational Study
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region A Retrospective Observational Study
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to assess the annual prevalence of ORCs among adult people with obesity in the real-world clinical setting across the Gulf region In addition the study will describe the annual HCRU and associated costs of obesity and ORCs describe the demographics and clinical characteristics of adult people with obesity as well as estimate the annual incidence and point prevalence of the ORCs among adult people with obesity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U1111-1292-7248 | OTHER | World Health Organization WHO | None |